Canada markets open in 3 hours 46 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.07500.0000 (0.00%)
At close: 09:45AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,598
2,668
1,608
1,342
1,694
Cost of Revenue
-
1,255
1,039
814.715
1,084
Gross Profit
1,266
1,413
568.441
526.859
609.912
Operating Expenses
Research Development
660.993
1,054
1,377
1,326
1,541
Selling General and Administrative
-
3,723
4,075
3,425
2,659
Total Operating Expenses
4,223
4,777
5,452
4,751
4,200
Operating Income or Loss
-2,957
-3,364
-4,884
-4,224
-3,590
Interest Expense
-
822.213
416.057
121.556
141.675
Total Other Income/Expenses Net
-
261.671
327.773
461.653
2,771
Income Before Tax
-
-3,824
-4,850
-3,846
-960.178
Income from Continuing Operations
-4,090
-3,824
-4,850
-3,846
-960.178
Net Income
-3,955
-3,890
-4,605
-3,717
-960.178
Net Income available to common shareholders
-3,955
-3,890
-4,605
-3,717
-960.178
Basic EPS
-
-0.03
-0.04
-0.03
-0.01
Diluted EPS
-
-0.03
-0.04
-0.03
-0.01
Basic Average Shares
-
120,702
112,600
108,614
82,304
Diluted Average Shares
-
120,702
112,600
108,614
82,304